Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | DDX3X |
| Upstream (Parents) |
|---|
| (<<) ACTB → DDX3X |
| (<<) SRSF1 → DDX3X |
| Downstream (Children) |
|---|
| DDX3X → OGT (>>) |
| DDX3X → VDAC1 (>>) |
| DDX3X → CDK2 (>>) |
| DDX3X → ZBTB46 (>>) |
| DDX3X → SHMT2 (>>) |
| DDX3X → CDH1 (>>) |
| DDX3X → ACTB (>>) |
| DDX3X → TAF9B (>>) |
| DDX3X → EIF2S3 (>>) |
| DDX3X → PTP4A1 (>>) |
| DDX3X → YWHAE (>>) |
| DDX3X → PRCC (>>) |
| DDX3X → XPO7 (>>) |
| DDX3X → SRSF1 (>>) |
| DDX3X → MPZL1 (>>) |
| DDX3X → BCLAF1 (>>) |
| DDX3X → MFN1 (>>) |
| DDX3X → CHP (>>) |
| DDX3X → GNS (>>) |
| DDX3X → NFYC (>>) |
| DDX3X → ACTR2 (>>) |
| DDX3X → BCL6 (>>) |
| DDX3X → PIP5K1A (>>) |
| DDX3X → RAB5A (>>) |
| DDX3X → FOXO3 (>>) |
| DDX3X → DCUN1D4 (>>) |
| DDX3X → MAP3K2 (>>) |
| DDX3X → PPP1R3B (>>) |
| DDX3X → STX16 (>>) |
| DDX3X → EZR (>>) |
| DDX3X → GDI2 (>>) |
| DDX3X → TOR1AIP1 (>>) |
| DDX3X → SPTLC1 (>>) |
| DDX3X → NUDT3 (>>) |
| DDX3X → CDK8 (>>) |
| DDX3X → GLE1 (>>) |
| DDX3X → RAB6A (>>) |
| DDX3X → MAT2A (>>) |
| DDX3X → EXOC5 (>>) |
| DDX3X → LRRC41 (>>) |
| DDX3X → DDX42 (>>) |
| DDX3X → SP1 (>>) |
| DDX3X → PTPN11 (>>) |
| DDX3X → SEPT2 (>>) |
| DDX3X → ACLY (>>) |
| DDX3X → CHMP1B (>>) |
| DDX3X → PPP6C (>>) |
| DDX3X → MEX3C (>>) |
| DDX3X → SPTBN1 (>>) |
| DDX3X → NNT (>>) |
| DDX3X → CDC27 (>>) |
| DDX3X → YAP1 (>>) |
